Nilotinib – Differentiating the Hope from the Hype
Author:
Affiliation:
1. The Cure Parkinson’s Trust, London, UK
2. Translational Parkinson’s Disease Research, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA
3. Michael J Fox Foundation for Parkinson’s Research, New York, USA
Publisher
IOS Press
Subject
Cellular and Molecular Neuroscience,Neurology (clinical)
Reference25 articles.
1. Pagan F , Hebron M , Valadez EH , Tores-Yaghi Y , Huang X , Mills RR , Wilmarth BM , Howard H , Dunn C , Carlson A , Lawler A , Rogers SL , Falconer R , Ahn J , Li Z , & Moussa C (2016) Nilotinib effects in Parkinson’s disease and dementia with Lewy bodies. J Parkinsons Dis.
2. Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia;Moslehi;J Clin Oncol,2015
3. Are nilotinib-associated vascular adverse events an under-estimated problem?;Stève-Dumont;Fundam Clin Pharmacol,2015
4. The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson’s disease;Karuppagounder;Sci Rep,2014
5. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin’s ubiquitination and protective function;Ko;Proc Natl Acad Sci U S A,2010
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Parkinson’s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment;Annals of Medicine & Surgery;2023-08-08
2. The Role of Clinical Medicine;Drug Repurposing;2022-02-09
3. Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's Disease;Pharmacological Reviews;2022-01
4. Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Patient’s Perspective;Journal of Parkinson's Disease;2021-09-22
5. Promising drug targets and associated therapeutic interventions in Parkinson’s disease;Neural Regeneration Research;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3